The vasorelaxant effect of anti-diabetic drug nateglinide via activation of voltage-dependent K+ channels in aortic smooth muscle
Cardiovascular Therapeutics Aug 26, 2017
Li H, et al. – This study was designed to assess the vasorelaxant impact of nateglinide and its associated mechanisms using phenylephrine (Phe)–induced pre–contracted aortic rings. Findings demonstrated that nateglinide induced vasorelaxation through the activation of the voltage-dependent K+ (Kv) channel independent of other K+ channels, Ca2+ channels, intracellular Ca2+ ([Ca2+]i), and the endothelium.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries